{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:35:12Z","timestamp":1774355712571,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd011841","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T00:00:00Z","timestamp":1450742400000}}],"reference-count":160,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011841.pub2","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T13:45:20Z","timestamp":1450791920000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Interventions for central serous chorioretinopathy: a network meta-analysis"],"prefix":"10.1002","volume":"2015","author":[{"given":"Mahsa","family":"Salehi","sequence":"first","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine; Department of Ophthalmology; Baltimore Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam S","family":"Wenick","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine; Department of Ophthalmology; Baltimore Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua Andrew","family":"Law","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health; Department of Epidemiology; 615 N. Wolfe Street Baltimore Maryland USA 21205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R","family":"Evans","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine; Cochrane Eyes and Vision, ICEH; Keppel Street London UK WC1E 7HT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gehlbach","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine; Retina Division, Wilmer Eye Institute; 1550 Orleans Street Cancer Research Building #2 Baltimore Maryland USA 21231"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,12,22]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2013.09.024","article-title":"Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial","volume":"121","author":"Bae","year":"2014","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajo.2011.04.008","article-title":"A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy","volume":"152","author":"Bae","year":"2011","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0003|cit3","unstructured":"Boscia F Michele R Antonio L Nicola C Claudio F Salvatore F Low fluence photodynamic therapy in chronic central serous chorioretinopathy: blind randomized clinical trial of efficacy and safety The Macula Society 2008 118"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0004|cit4","unstructured":"Boscia F Reibaldi M Longo A Faro S Uva M Cardascia N Low fluence photodynamic therapy in chronic central serous chorioretinopathy: blind randomised clinical trial of efficacy and safety Investigative Ophthalmology and Visual Science 2008 ARVO E-abstract 3278"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0005|cit5","unstructured":"Brancato R Bandello F Treatment of central serous chorioretinopathy with beta-blockers and calcium antagonists The Macula Society 1994 114"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0006|cit6","doi-asserted-by":"crossref","unstructured":"Browning DJ Nadolol in the treatment of central serous retinopathy American Journal of Ophthalmology 1993 770 1","DOI":"10.1016\/S0002-9394(14)73483-X"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0007|cit7","unstructured":"Chan PS Uy HS Salvosa F Silva PA Low dose transpupillary thermotherapy for the treatment of central serous chorioretinopathy American Academy of Ophthalmology 2006 290"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","article-title":"Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial","volume":"115","author":"Chan","year":"2008","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/FTD.0b013e31820beb02","article-title":"Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial","volume":"31","author":"Wu","year":"2011","journal-title":"Retina"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0010|cit10","first-page":"56","article-title":"Combined half dose photodynamic therapy with verteporfin and intravitreal bevacizumab for chronic central serous chorioretinopathy","volume":"232","author":"Coskun","year":"2014","journal-title":"Ophthalmologica"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"Dang Y Mu Y Zhao M Li L Guo Y Zhu Y The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients Therapeutics and Clinical Risk Management 2013 355 60","DOI":"10.2147\/TCRM.S50407"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0012|cit12","first-page":"103","article-title":"Effects of propranolol in patients with central serous chorioretinopathy","volume":"13","author":"Kianersi","year":"2008","journal-title":"Journal of Research in Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000345495","article-title":"Intravitreal ranibizumab for acute central serous chorioretinopathy","volume":"229","author":"Kim","year":"2013","journal-title":"Ophthalmologica"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0014|cit14","doi-asserted-by":"crossref","unstructured":"Klatt C Saeger M Oppermann T P\u00f6rksen E Treumer F Hillenkamp J Selective retina therapy for acute central serous chorioretinopathy British Journal of Ophthalmology 2011 83 8","DOI":"10.1136\/bjo.2009.178327"},{"issue":"Pt 4","key":"10.1002\/14651858.CD011841.pub2-BIB0015|cit15","first-page":"473","article-title":"Long term results of treatment of central serous retinopathy - a preliminary report","volume":"105","author":"Ficker","year":"1986","journal-title":"Transactions of the Ophthalmological Societies of the United Kingdom"},{"issue":"11","key":"10.1002\/14651858.CD011841.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.72.11.829","article-title":"Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy","volume":"72","author":"Ficker","year":"1988","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0017|cit17","doi-asserted-by":"crossref","unstructured":"Leaver P Williams C Argon laser photocoagulation in the treatment of central serous retinopathy British Journal of Ophthalmology 1979 674 7","DOI":"10.1136\/bjo.63.10.674"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3341\/kjo.2010.24.3.155","article-title":"The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy","volume":"24","author":"Lim","year":"2010","journal-title":"Korean Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0020|cit19","unstructured":"Ontiveros-Orozco I Garcia-Franco R Levine-Berebichez A Celis-Suazo B Rojas-Juarez S Topical brinzolamide for the treatment of idiopathic central serous chorioretinopathy Investigative Ophthalmology and Visual Science 2004 ARVO E-abstract 529"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0019|cit20","first-page":"132","article-title":"Brinzolamide for topical treatment coroidorretinopat\u00eda idiopathic central serous","volume":"80","author":"Ontiveros-Orozco","year":"2006","journal-title":"Revista Mexicana de Oftalmolog\u00eda"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bjophthalmol-2014-306018","article-title":"A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study","volume":"99","author":"Pitcher","year":"2015","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0022|cit22","first-page":"99","article-title":"The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy","volume":"17","author":"Rahbani-Nobar","year":"2011","journal-title":"Molecular Vision"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2415-12-20","article-title":"High-dose antioxidants for central serous chorioretinopathy; the randomized placebo-controlled study","volume":"12","author":"Ratanasukon","year":"2012","journal-title":"BMC Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9394(83)90265-9","article-title":"Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy","volume":"95","author":"Robertson","year":"1983","journal-title":"American Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3928\/23258160-20130909-08","article-title":"Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial","volume":"44","author":"Roisman","year":"2013","journal-title":"Ophthalmic Surgery Lasers and Imaging"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Sawa M Gomi F Hara C Nishida K Effects of a lutein supplement on the plasma lutein concentration and macular pigment in patients with central serous chorioretinopathy Investigative Ophthalmology and Visual Science 2014 5238 44","DOI":"10.1167\/iovs.14-14470"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10384-012-0162-3","article-title":"Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy","volume":"56","author":"Semeraro","year":"2012","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub2-BIB0028|cit28","first-page":"413","article-title":"Wavelength selection in management of central serous chorioretinopathy","volume":"35","author":"Shang","year":"1999","journal-title":"Chinese Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2415-4-15","article-title":"Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial. ISRCTN84128484","volume":"4","author":"Verma","year":"2004","journal-title":"BMC Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD011841.pub2-BIB0030|cit30","first-page":"1030","article-title":"Different doses of verteporfin photodynamic therapy for central exudative chorioretinopathy","volume":"30","author":"Zhang","year":"2012","journal-title":"Chinese Journal of Experimental Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamaophthalmol.2014.5312","article-title":"A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial","volume":"133","author":"Zhao","year":"2015","journal-title":"JAMA Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub2-BIB0032|cit32","first-page":"1841","article-title":"Efficacy of compound Xueshuantong combined laser therapy on central serous chorioretinopathy","volume":"14","author":"Ainiwaer","year":"2014","journal-title":"International Eye Science"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00417-011-1884-5","article-title":"Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy","volume":"251","author":"Arevalo","year":"2013","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/jop.2012.0072","article-title":"The efficacy of intravitreal bevacizumab for acute central serous chorioretinopathy","volume":"29","author":"Aydin","year":"2013","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00347-012-2688-7","article-title":"Treatment of central serous chorioretinopathy: micropulse photocoagulation versus bevacizumab","volume":"109","author":"Beger","year":"2012","journal-title":"Der Ophthalmologe"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/IAE.0b013e3182670fa3","article-title":"Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy","volume":"33","author":"Behnia","year":"2013","journal-title":"Retina"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0037|cit37","first-page":"166","article-title":"Treatment of central serous chorioretinopathy with krypton yellow and green laser photocoagulation","volume":"9","author":"Bi","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0038|cit38","unstructured":"Boscia F Caradscia N Furino C Dammacco R Sborgia G Reibaldi M Photodynamic therapy with low fluence PDT for chronic central serous chorioretinopathy: a short term pilot study Investigative Ophthalmology and Visual Science 2007 ARVO E-Abstract 4151"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0039|cit39","first-page":"340","article-title":"Therapy of the so-called chorioretinitis centralis serosa with the laser-coagulator","volume":"160","author":"Bruha","year":"1972","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub2-BIB0040|cit40","first-page":"525","article-title":"Low dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"83","author":"Cervera","year":"2008","journal-title":"Archivos de la Sociedad Espanola de Oftalmologia"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5507\/bp.2013.015","article-title":"Treatment of central serous chorioretinopathy with beta-blocker metipranolol","volume":"159","author":"Chrapek","year":"2015","journal-title":"Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, Czech Republic"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011841.pub2-BIB0042|cit42","first-page":"60","article-title":"The comparison of reduced-fluence photodynamic therapy with 577 nm yellow-wavelength pattern micropulse laser therapy in cases with chronic central serous chorioretinopathy: short term results","volume":"232","author":"Demirel","year":"2014","journal-title":"Ophthalmologica"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0043|cit43","first-page":"336","article-title":"Changes in visual function before and after laser photocoagulation of central serous chorioretinopathy","volume":"13","author":"Di","year":"2013","journal-title":"International Eye Science"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ophtha.2014.06.038","article-title":"Visual cycle suppression via patching in central serous chorioretinopathy","volume":"121","author":"Earl","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0045|cit45","first-page":"740","article-title":"Argon laser treatment of central serous chorioretinopathy","volume":"13","author":"Fang","year":"2013","journal-title":"International Eye Science"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0046|cit46","first-page":"434","article-title":"The potential utility of coumarin and horse chestnut extract for treatment of central serous chorioretinopathy","volume":"18","author":"Feily","year":"2009","journal-title":"Nigerian Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0047|cit47","first-page":"104","article-title":"Photodynamic therapy in patients with central serous chorioretinopathy","volume":"18","author":"Haas","year":"2004","journal-title":"Spektrum der Augenheilkunde"},{"issue":"5-6","key":"10.1002\/14651858.CD011841.pub2-BIB0048|cit48","first-page":"681","article-title":"Central serous retinopathy and alpha-blockaders","volume":"74","author":"Heinrich","year":"1974","journal-title":"Bulletin des Soci\u00e9t\u00e9s d'Ophtalmologie de France"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub2-BIB0049|cit49","first-page":"546","article-title":"Clinical effectiveness of lecithin-bound iodine on central serous chorioretinopathy following laser photocoagulation","volume":"24","author":"Huang","year":"2006","journal-title":"Chinese Ophthalmic Research"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3928\/1542-8877-19970801-16","article-title":"Evaluation of visual function following argon laser photocoagulation in central serous retinopathy","volume":"28","author":"Khosla","year":"1997","journal-title":"Ophthalmic Surgery and Lasers"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/eye.2011.282","article-title":"Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy","volume":"26","author":"Koss","year":"2012","journal-title":"Eye"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub2-BIB0052|cit52","first-page":"841","article-title":"Effect of adenosine monophosphate on retinitis centralis","volume":"20","author":"Kurimoto","year":"1969","journal-title":"Nihon Ganka Kiyo"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0053|cit53","first-page":"e293","article-title":"Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy","volume":"89","author":"Lee","year":"2011","journal-title":"Acta Opthalmologica"},{"issue":"15","key":"10.1002\/14651858.CD011841.pub2-BIB0054|cit54","first-page":"2145","article-title":"Intravitreal bevacizumab injection for chronic central serous chorioretinopathy","volume":"123","author":"Li","year":"2010","journal-title":"Chinese Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bjo.2010.182121","article-title":"Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy","volume":"95","author":"Lim","year":"2011","journal-title":"British Journal of Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub2-BIB0056|cit56","first-page":"2451","article-title":"532 Laser photocoagulation for the treatment of central serous chorioretinopathy","volume":"9","author":"Liu","year":"2009","journal-title":"International Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0057|cit57","first-page":"330","article-title":"Study in krypton laser combined with compound anisodine for central serous chorioretinopathy","volume":"11","author":"Long","year":"2011","journal-title":"International Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0058|cit58","first-page":"214","article-title":"Conservative management of central serous retinopathy","volume":"97","author":"Lyons","year":"1977","journal-title":"Transactions of the Ophthalmological Societies of the United Kingdom"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0059|cit59","first-page":"162","article-title":"Comparison of late results of conservative treatment and laser coagulation of central serous chorioretinopathy","volume":"89","author":"Mackowiakowa","year":"1987","journal-title":"Klinika Oczna"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0060|cit60","first-page":"603","article-title":"Successful treatment of central serous retinopathy by tranexamic acid injection","volume":"75","author":"Miyashita","year":"1971","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0061|cit61","unstructured":"NCT01256580 Pilot study of intravitreal bevacizumab vs. combination therapy for choroidal neovascularization secondary to causes other than age-related macular degeneration clinicaltrials.gov\/ct2\/show\/NCT01256580"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0062|cit62","unstructured":"NCT01585441 Phase II, randomized, placebo-controlled study for the evaluation of finasteride in the treatment of chronic central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01585441"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00006982-198700730-00005","article-title":"Krypton and argon laser photocoagulation for central serous chorioretinopathy","volume":"7","author":"Novak","year":"1987","journal-title":"Retina"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0064|cit64","doi-asserted-by":"crossref","unstructured":"Okamoto M Matsuura T Ogata N Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy Ophthalmic Surgery Lasers and Imaging Retina 2015 25 32","DOI":"10.3928\/23258160-20150101-04"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/15569527.2013.812104","article-title":"Morphologic changes and visual outcomes in resolved central serous chorioretinopathy treated with ranibizumab","volume":"33","author":"Ozdemir","year":"2014","journal-title":"Cutaneous and Ocular Toxicology"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub2-BIB0066|cit66","first-page":"1284","article-title":"Clinical study of method of activating blood and diuresis on central serous","volume":"10","author":"Peng","year":"2010","journal-title":"International Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0067|cit67","first-page":"299","article-title":"Enzymatic treatment of central serous retinopathy","volume":"28","author":"Radian","year":"1984","journal-title":"Revista de Chirurgie, Oncologie, Radiologie, ORL, Oftalmologie, Stomatologie. Oftalmologie"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0068|cit68","first-page":"44","article-title":"Mifepristone as a treatment alternative to chronic serous chorioretinopathy","volume":"34","author":"Sanchez-Pacheco Tardon","year":"2010","journal-title":"Farmacia Hospitalaria"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub2-BIB0069|cit69","first-page":"420","article-title":"Statistic studies of retinitis centralis","volume":"16","author":"Takagi","year":"1965","journal-title":"Nippon Ganka Kiyo"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0070|cit70","first-page":"251","article-title":"Argon laser photocoagulation in treatment of central serous retinopathy - a prospective randomized study","volume":"34","author":"Tewari","year":"1986","journal-title":"Indian Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0071|cit71","first-page":"384","article-title":"Clinical analysis of argon laser in treating central serous chorioretinopathy","volume":"9","author":"Wang","year":"2009","journal-title":"International Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub2-BIB0072|cit72","first-page":"1169","article-title":"Clinical observation of alliance application of compound anisodine and joletion in the treatment of central serous chorioretinopathy","volume":"9","author":"Wang","year":"2009","journal-title":"International Journal of Ophthalmology"},{"issue":"0","key":"10.1002\/14651858.CD011841.pub2-BIB0073|cit73","first-page":"242","article-title":"Ruby laser photocoagulation therapy of central serous retinopathy. A preliminary report","volume":"12","author":"Watzke","year":"1974","journal-title":"Modern Problems in Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0002-9394(79)90571-3","article-title":"Direct and indirect laser photocoagulation of central serous choroidopathy","volume":"88","author":"Watzke","year":"1979","journal-title":"American Journal of Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub2-BIB0075|cit75","first-page":"2295","article-title":"Clinical observation of Jolethin combined with argon laser for central serous chorioretinopathy","volume":"10","author":"Wu","year":"2010","journal-title":"International Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub2-BIB0076|cit76","first-page":"1688","article-title":"Efficacy comparison of 577nm micro-pulse laser and drug in the treatment of central serous chorioretinopathy","volume":"13","author":"Xu","year":"2013","journal-title":"International Eye Science"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0077|cit77","first-page":"701","article-title":"Treatment of juxtafoveal central serous chorioretinopathy by compound anisodine injection","volume":"14","author":"Xu","year":"2014","journal-title":"International Eye Science"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub2-BIB0078|cit78","first-page":"1160","article-title":"Compound Xueshuantong capsule joint laser treating central serous chorioretinopathy","volume":"13","author":"Ye","year":"2013","journal-title":"International Eye Science"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub2-BIB0079|cit79","first-page":"872","article-title":"Clinical observation of laser treatment for central serous chorioretinopathy choroidal diseases and study on relationship between visual acuity with leakage location","volume":"14","author":"Zhang","year":"2014","journal-title":"International Eye Science"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub2-BIB0080|cit80","first-page":"2124","article-title":"Hyperbaric oxygen therapy combined with jolethin in treating central serous chorioretinopathy","volume":"13","author":"Zheng","year":"2013","journal-title":"International Eye Science"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0081|cit81","unstructured":"EUCTR2009-017959-98-NL Early treatment of patients with central serous retinopathy: a randomized controlled trial - CSR & PDT apps.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2009-017959-98-NL"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0082|cit82","unstructured":"JPRN-UMIN000005372 Study on the effects of supplements containing lutein on spontaneous resolution in eyes with chronic central serous chorioretinopathy apps.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000005372"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0083|cit83","unstructured":"NCT01019668 Central serous chorioretinopathy treated by modified photodynamic therapy clinicaltrials.gov\/ct2\/show\/NCT01019668"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0084|cit84","unstructured":"NCT01552044 Effect of spironolactone in treating chronic non-resolutive central serous chorioretinitis clinicaltrials.gov\/ct2\/show\/NCT01552044"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0085|cit85","unstructured":"NCT01630863 The safe effective light dose of photodynamic therapy for chronic central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01630863"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13063-015-0939-z","article-title":"Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial","volume":"16","author":"Breukink","year":"2015","journal-title":"TRIALS"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0087|cit87","unstructured":"NCT01797861 A prospective randomized controlled multicentre trial comparing half-dose photodynamic therapy (PDT) with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (CSC) clinicaltrials.gov\/ct2\/show\/NCT01797861"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0088|cit88","unstructured":"NCT01971190 Efficacy and safety of intravitreal aflibercept injection for subacute central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01971190"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0089|cit89","unstructured":"NCT01982383 A prospective study of the use of micropulse 577nm laser treatment in central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01982383"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0090|cit90","unstructured":"NCT01990677 Eplerenone for the treatment of central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT01990677"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0091|cit91","unstructured":"NCT02153125 Eplerenone for the treatment of chronic central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT02153125"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0092|cit92","unstructured":"NCT02215330 A randomized, double-masked, placebo controlled study of the beneficial effects of eplerenone on central serous chorioretinopathy clinicaltrials.gov\/ct2\/show\/NCT02215330"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0093|cit93","unstructured":"NCT02354170 Short-term oral mifepristone for central serous chorioretinopathy. A placebo-controlled dose ranging study of mifepristone in the treatment of CSC (STOMP-CSC) clinicaltrials.gov\/ct2\/show\/NCT02354170"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.eye.6701905","article-title":"Central serous chorioretinopathy associated with testosterone therapy","volume":"20","author":"Ahad","year":"2006","journal-title":"Eye"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1442-9071.2005.01027.x","article-title":"Long-term macular function in eyes with central serous chorioretinopathy","volume":"33","author":"Baran","year":"2005","journal-title":"Clinical and Experimental Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":"Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","article-title":"Central serous chorioretinopathy and glucocorticoids","volume":"47","author":"Bouzas","year":"2002","journal-title":"Survey of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00006982-200312000-00002","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy","volume":"23","author":"Cardillo Piccolino","year":"2003","journal-title":"Retina"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0100|cit100","volume-title":"Dictionary of Eye Terminology","author":"Cassin","year":"2006"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00169099","article-title":"Long-term follow-up of central serous retinopathy in 150 patients","volume":"81","author":"Castro-Correia","year":"1992","journal-title":"Documenta Ophthalmologica"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0002-9394(03)00462-8","article-title":"Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin","volume":"136","author":"Chan","year":"2003","journal-title":"American Journal of Opthalmology"},{"issue":"12","key":"10.1002\/14651858.CD011841.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.ophtha.2008.08.026","article-title":"Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage","volume":"115","author":"Chen","year":"2008","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1507\/endocrj.47.401","article-title":"Long-term effects of ketoconazole in the treatment of residual or recurrent Cushing's disease","volume":"47","author":"Chou","year":"2000","journal-title":"Endocrine Journal"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/eye.2013.236","article-title":"Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review","volume":"27","author":"Chung","year":"2013","journal-title":"Eye"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/sj.mp.4002041","article-title":"Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57\/Bl6 mice","volume":"13","author":"Clark","year":"2008","journal-title":"Molecular Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/112067210601600213","article-title":"Central serous chorioretinopathy and Helicobacter pylori","volume":"16","author":"Cotticelli","year":"2006","journal-title":"European Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0109|cit109","unstructured":"Covidence www.covidence.org"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub2-BIB0110|cit110","first-page":"1190","article-title":"Treatment of chronic macular edema with acetazolamide","volume":"106","author":"Cox","year":"1988","journal-title":"JAMA Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0111|cit111","unstructured":"Drugs@FDA U.S. Food and Drug Administration https:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/IAE.0b013e3181f04a35","article-title":"Finasteride for chronic central serous chorioretinopathy","volume":"31","author":"Forooghian","year":"2011","journal-title":"Retina"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0113|cit113","first-page":"S1","article-title":"Pathogenesis of disciform detachment of the neuroepithelium","volume":"63","author":"Gass","year":"1967","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.mehy.2004.02.020","article-title":"Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis","volume":"63","author":"Giusti","year":"2004","journal-title":"Medical Hypotheses"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0115|cit115","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/bjo.2006.098277","article-title":"The potential role of testosterone in central serous chorioretinopathy","volume":"91","author":"Grieshaber","year":"2007","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome P-450 3A4: regulation and role in drug metabolism","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":"Risk factors for central serous chorioretinopathy: a case-control study","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"issue":"7414","key":"10.1002\/14651858.CD011841.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0121|cit121","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0123|cit123","volume-title":"Visual Science and Related Clinical Terms","author":"Hofstetter","year":"2000"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0002-9394(98)00378-X","article-title":"Plasminogen activator inhibitor 1 in central serous chorioretinopathy","volume":"127","author":"Iijima","year":"1999","journal-title":"American Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0161-6420(02)01303-9","article-title":"Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3928\/15428877-20090430-14","article-title":"Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy","volume":"40","author":"Kim","year":"2009","journal-title":"Ophthalmic Surgery, Lasers and Imaging Retina"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","article-title":"The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002","volume":"115","author":"Kitzmann","year":"2008","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011841.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archopht.1974.03900060257001","article-title":"Experience with nontreatment of central serous choroidopathy","volume":"91","author":"Klein","year":"1974","journal-title":"Archives of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bjo.2006.090282","article-title":"Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study","volume":"90","author":"Lai","year":"2006","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","article-title":"Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy","volume":"121","author":"Lim","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006982-200202000-00004","article-title":"Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy","volume":"22","author":"Loo","year":"2002","journal-title":"Retina"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1111\/aos.12482","article-title":"System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy","volume":"92","author":"Ma","year":"2014","journal-title":"Acta Ophthalmologica"},{"issue":"10","key":"10.1002\/14651858.CD011841.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jfo.2014.05.007","article-title":"Central serous chorioretinopathy: clinical-anatomic correlations","volume":"37","author":"Maalej","year":"2014","journal-title":"Journal Fran\u00e7ais d'Ophtalmologie"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","article-title":"Subfoveal choroidal thickness after treatment of central serous chorioretinopathy","volume":"117","author":"Maruko","year":"2010","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/IAE.0b013e318050ca69","article-title":"Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy","volume":"27","author":"Meyerle","year":"2007","journal-title":"Retina"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0136|cit136","first-page":"291","article-title":"Xenon light-exposure as a treatment of central serous retinopathy (a preliminary report)","volume":"20","author":"Mitsui","year":"1969","journal-title":"Nippon Ganka Kiyo"},{"issue":"5","key":"10.1002\/14651858.CD011841.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/bjo.2004.049403","article-title":"Optical coherence tomography characterisation of idiopathic central serous chorioretinopathy","volume":"89","author":"Montero","year":"2005","journal-title":"British Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/IAE.0b013e318156db8a","article-title":"The natural history of pigment epithelial detachment associated with central serous chorioretinopathy","volume":"27","author":"Mudvari","year":"2007","journal-title":"Retina"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Survey of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(14)70531-8","article-title":"Choriodal capillary and venous congestion in central serous chorioretinopathy","volume":"121","author":"Prunte","year":"1996","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1442-9071.2012.02847.x","article-title":"Diagnosis and interventions for central serous chorioretinopathy: review and update","volume":"41","author":"Quin","year":"2013","journal-title":"Clinical and Experimental Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ajo.2009.08.026","article-title":"Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial","volume":"149","author":"Reibaldi","year":"2010","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0144|cit144","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/112067210401400115","article-title":"Indocyanine green dye-enhanced micropulsed diode laser: a novel approach to subthreshold RPE treatment in a case of central serous chorioretinopathy","volume":"14","author":"Ricci","year":"2004","journal-title":"European Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD011841.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","article-title":"Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes","volume":"240","author":"Schl\u00f6tzer-Schrehardt","year":"2002","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD011841.pub2-BIB0147|cit147","first-page":"830","article-title":"Photodynamic effects on choroidal neovascularization and physiological choroid","volume":"43","author":"Schmidt-Erfurth","year":"2002","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0148|cit148","unstructured":"Shuler RK Mruthyunjaya P Diagnosing and managing central serous chorioretinopathy EyeNet Magazine, February 2006. Available at www.aao.org\/publications\/eyenet\/200602\/pearls.cfm"},{"issue":"6","key":"10.1002\/14651858.CD011841.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.survophthal.2010.02.005","article-title":"Micropulsed diode laser therapy: evolution and clinical applications","volume":"55","author":"Sivaprasad","year":"2010","journal-title":"Survey of Ophthalmology"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0150|cit150","unstructured":"Sterne JAC Egger M Moher D Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0151|cit151","unstructured":"Systematic Review Data Repository (SRDR) srdr.ahrq.gov\/"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","article-title":"Central serous chorioretinopathy","volume":"86","author":"Wang","year":"2008","journal-title":"Acta Opthalmologica"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1536867X0900900103","article-title":"Multivariate random-effects meta-analysis","volume":"9","author":"White","year":"2009","journal-title":"Stata Journal"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1536867X1101100206","article-title":"Multivariate random-effects meta-regression: updates to mvmeta","volume":"11","author":"White","year":"2011","journal-title":"Stata Journal"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"1","key":"10.1002\/14651858.CD011841.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1200\/JCO.1995.13.1.157","article-title":"Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin production","volume":"13","author":"Winquist","year":"1995","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD011841.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-198700720-00009","article-title":"Type-A behavior and central serous chorioretinopathy","volume":"7","author":"Yannuzzi","year":"1987","journal-title":"Retina"},{"key":"10.1002\/14651858.CD011841.pub2-BIB0158|cit158","volume-title":"Ophthalmology","author":"Yanoff","year":"2013"},{"issue":"7","key":"10.1002\/14651858.CD011841.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10.1002\/14651858.CD011841.pub2-BIB0160|cit160","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011841","article-title":"Interventions for central serous chorioretinopathy: a network meta-analysis","author":"Salehi","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011841.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD011841.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T17:20:15Z","timestamp":1703092815000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011841.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,22]]},"references-count":160,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011841.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD011841.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,22]]}}}